InsidersTradesSigma
Explore the full record of transactions filed by Byrnes Michael, Chief Financial Officer. Officer active across 1 companies, notably eFFECTOR Therapeutics, Inc.. Cumulatively, 2 reports have been logged. Total volume traded: €31k. The latest transaction was disclosed on 7 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Byrnes Michael is the Chief Financial Officer of eFFECTOR Therapeutics, Inc. He oversees the company's financial strategy, including financial planning and financial reporting. His role is essential in ensuring the financial health and development of the organization.